#1 Startup Dataset
Growth rates, revenue data, direct competitors and contact details.
Pete Gelinas Email
SVP CMC . AffyImmune Therapeutics
How to contact Pete Gelinas
Join and see Pete's contact info for free!Current Roles
Employees:
33Revenue:
$2.6MAbout
Founded in 2016, AffyImmune is a clinical-stage biotechnology company that optimizes CAR T cells for the treatment of solid tumors using our Tune & Track platform. AIC100, our first product, spares healthy cells through our unique affinity-tuning, enhancing its safety and efficacy. The initial indication for AIC100 is refractory thyroid cancer, which has a very poor prognosis and very few effective therapies. The antigen targeted by AIC100 is also overexpressed in a variety of additional cancers, including stomach, triple negative breast cancer and a number of others.AffyImmune Therapeutics Address
22 Strathmore RoadNatick, MA